Investigation on Brazilian clinical practices in rheumatoid arthritis the Brazilian rheumatoid arthritis clinical practices investigation-bractice

Journal of Clinical Rheumatology

Volumn 17, Issue 4, 2011, Pages

  Helfenstein, Milton ^a   Halpern, Ari Stiel Radu ^b,c   Bertolo, Manoel Barros ^d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Consensus; Drug treatment; Guidelines; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; BRAZIL; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG CHOICE; HUMAN; INTERNET; MEDICAL SOCIETY; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRAZIL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RHEUMATOLOGY; YOUNG ADULT;

EID: 80051733393     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182224ea4     Document Type: Article

References (27)

1. Turesson C, Matteson EL. Genetics of rheumatoid arthritis. Mayo Clin Proc. 2006;81:94-101. (Pubitemid 43054987)
2. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005;4:130-136. (Pubitemid 40488741)
3. Gabriel S. The epidemiology of rheumatoid arthritis. Rheum Dis Clin N Am. 2001;27:269-281. (Pubitemid 32488705)
4. Puokakka K, Kautianen H, Mottonen T, et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis. 2005;64:130-134.
5. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494. (Pubitemid 24115934)
6. Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum. 2001;44:2746-2749. (Pubitemid 34016193)
7. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinate antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65: 845-851.
8. Boyesen P, Haavardsholm EA, Ostergaard M, et al. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression. Ann Rheum Dis. 2011;70:428-433.
9. Kstergaard M, Szkudlarek M. Imaging in rheumatoid arthritisVwhy MRI and ultrasonography can no longer be ignored. Scand J Rheumatol. 2003;32:63-73. (Pubitemid 36428342)
10. Visser H, le Cessie S, Vos K, Breedveld FC et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46:357-365. (Pubitemid 34136572)
11. Le Loët X, Berthelot JM, Cantagrel A, et al. Clinical practice decision tree for the choice of the first disease-modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis. 2006;65:45-50. (Pubitemid 41815638)
12. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762-784. (Pubitemid 351847559)
13. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 2002;46:328-346.
14. Madison P, Kiely P, Kirkham B, et al. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. Rheumatology. 2005;44:280-286. (Pubitemid 40361281)
15. Laurindo IMM, Ximenes AC, Lima FAC, et al. Artrite reumatóide: diagnóstico e tratamentoVreunião consensual multidisciplinar. Rev Bras Reumatol. 2004;44:435-442.
16. Bértolo MB, Brenol CV, Schainberg CG, et al. Atualizaç ão do Consenso Brasileiro no diagnóstico e tratamento da artrite reumatóide [Update on the Brazilian consensus for the diagnosis and treatment of rheumatoid arthritis]. Rev Bras Reumatol. 2007;47:151-159.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324. (Pubitemid 18091653)
18. Strand V, Tugwell P, Bombardier C, et al. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Arthritis Rheum. 1999;42: 1870-1878. (Pubitemid 30257751)
19. Cohen S, Cannon GW, Schiff M, et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigators Group. Arthritis Rheum. 2001;44:1984-1992. (Pubitemid 33644039)
20. Emery P, Breedveld FC, Lemmel EM, et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2000;39:655-665. (Pubitemid 30459953)
21. Strand V, Scott DL, Emery P, et al. Physical function and health related quality of life: analysis of 2-year data from randomized controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol. 2005;32:590-601. (Pubitemid 40524689)
22. Strand V, Cohen S, Schiff M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med. 1999;159:2542-2550.
23. Felson DT, Anderson JA, Meenan RF. The comparative efficacy and toxicity of second line drugs in rheumatoid arthritis. Results of 2 meta-analyses. Arthritis Rheum. 1990;33:1449-1461. (Pubitemid 20362087)
24. Van der Heijde D, Van Riel P, Nuver Swart I, et al. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989;1:1036-1038. (Pubitemid 19123055)
25. Weinblatt ME, Kremer JM, Coblyn JS, et al. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum. 1999;42:1322-1328. (Pubitemid 30265588)
26. Cohen S, Schiff M, Weaver A, et al. Leflunomide (LEF) as initial therapy with methotrexate (MTX) added for rheumatoid arthritis patients with active disease [abstract]. Arthritis Rheum. 2002;(suppl 46):S352.
27. Kremer JM, Genovese M, Cannon G, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137:726-733. (Pubitemid 35265316)